Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.40 |
| ▸ | MEN1 | O00255 | 7/20 | 0.40 |
| ▸ | RAB9A | P51151 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 8/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | RAF1 | P04049 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4137698 | 1.00 | KMT2A (0.40) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL7883529 | 0.81 | ALDH1A1 (0.53) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL7883531 | 0.81 | ALDH1A1 (0.53) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL8380227 | 0.81 | MAPT (0.44) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL8380230 | 0.81 | MAPT (0.44) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL9178347 | 0.79 | NPC1 (0.54) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL9178354 | 0.79 | NPC1 (0.54) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL9514033 | 0.75 | CA1 (0.34) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL15189810 | 0.72 | MEN1 (0.39) | KMT2AMEN1RAB9ANPC1L3MBTL1 | |
| SCHEMBL9817551 | 0.71 | KMT2A (0.38) | KMT2AMEN1RAB9ANPC1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | claimed |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | L'OREAL (FR) | 2009-03-19 | — | — | US | claimed |
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | L'OREAL (FR) | 2005-01-13 | — | — | US | claimed |
| EP-1484051-A2 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | L'OREAL (FR) | 2004-12-08 | — | — | EP | claimed |
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | disclosed |
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | disclosed |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | L'OREAL (FR) | 2009-03-19 | — | — | US | disclosed |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | L'OREAL (FR) | 2009-03-19 | — | — | US | disclosed |
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | L'OREAL (FR) | 2005-01-13 | — | — | US | disclosed |
| EP-1484051-A2 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | L'OREAL (FR) | 2004-12-08 | — | — | EP | disclosed |
| US-6203578-B1 | ORGANOSILICON CONTAINING ANTHRAQUINONE DYE, MONOAZO DYES, QUINONE DYES | L'OREAL (FR) | 2001-03-20 | — | — | US | disclosed |
| US-6176885-B1 | MODIFIED POLYSILOXANE OLIGOMER | L'OREAL (FR) | 2001-01-23 | — | — | US | disclosed |
| EP-0839815-B1 | Use of silicon compounds for dyeing human keratinic fibres; compounds and compositions | OREAL (FR) | 2000-03-01 | — | — | EP | disclosed |
| US-6027537-A | LINEAR OR CYCLIC POLYSILOXANES ENDCAPPED WITH OR CONTAINING AT LEAST ONE CHROMOPHORIC GROUP OF QUINONE OR AZO TYPE AS DIRECT DYES IN DYE COMPOSITIONS FOR DYEING HAIR | L'OREAL (FR) | 2000-02-22 | — | — | US | disclosed |
| EP-0839815-A1 | Use of silicon compounds for dyeing human keratinic fibres; compounds and compositions | L'OREAL (FR) | 1998-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | TYR, AAAS, ALAD | KMT2A 1215/4885MEN1 3700/4885RAB9A 2539/4885 |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | TYR, AAAS, ALAD | KMT2A 1027/4885MEN1 3854/4885RAB9A 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.